Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in the Bloomberg BNA Health Care Daily Report, in “Outlook 2018: Pharma/Life Sciences Law and Policy,” by Bronwyn Mixter, Jeannie Baumann, Dana A. Elfin, and Greg Langlois. (Read the full version – subscription required.)

Following is an excerpt:

Will the 21st Century Cures Act further its aim to boost drug and device development in 2018? That’s one of the questions the life sciences industry and attorneys are asking for the new year. The law provides extra money for research and development — including ambitious research into cancer and a landmark precision medicine project involving 1 million Americans — and spurs more use of real-world evidence to support product approvals.

Other issues to watch in 2018 include what the HHS and the NIH will do to help fight the nation’s opioid epidemic. In Congress, after a year of no action, there is still plenty of talk about prescription drug prices, and that debate could affect the midterm elections. Scott Gottlieb starts his first full year as commissioner of the Food and Drug Administration and says approving more generics will help keep prices down. …

For the medical device industry, what the FDA should do regarding laboratory-developed tests is pressing, but remains unsettled.

“The federal government, as a whole, including Congress, has been unable to come up with an appropriate regulatory pathway that both protects patients and advances innovation,” Bloomberg Law board member Bradley Merrill Thompson of Epstein Becker & Green said.

“It’s rather unbelievable that such an important issue should take so long to resolve,” he said.

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.